Post-IPO Equity - Otonomy
Investment Firm
Overview
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Announced Date
Jan 06, 2016
Closed on Date
Jan 12, 2016
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Otonomy raised $115000000 on 2016-01-06 in Post-IPO Equity
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2014 |  Series D - Otonomy | 12 | - | 49.0M |
| Sep 04, 2013 | Series C - Otonomy | 8 | - | 45.9M |
| Aug 30, 2010 | Series B - Otonomy | 4 | - | 38.5M |
| Jun 11, 2010 | Series A - Otonomy | 1 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.